Standard BioTools
LAB
LAB
141 hedge funds and large institutions have $543M invested in Standard BioTools in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 144 → 141 (-3)
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
21% less call options, than puts
Call options by funds: $72K | Put options by funds: $91K
Holders
141
Holding in Top 10
4
Calls
$72K
Puts
$91K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$10.7M | |
| 3 | +$4.46M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$3.14M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$3.08M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$2.11M | |
| 3 | -$2.05M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$2.05M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$1.68M |